In vitrosusceptibilities ofLeptospiraspp. andBorrelia burgdorferiisolates to amoxicillin, tilmicosin, and enrofloxacin
Open Access
- 1 January 2006
- journal article
- Published by The Korean Society of Veterinary Science in Journal of Veterinary Science
- Vol. 7 (4) , 355-359
- https://doi.org/10.4142/jvs.2006.7.4.355
Abstract
Antimicrobial susceptibility testing was conducted with 6 different spirochetal strains (4 strains of Leptospira spp. and 2 strains of Borrelia burgdorferi) against 3 antimicrobial agents, commonly used in equine and bovine practice. The ranges of MIC and MBC of amoxicillin against Leptospira spp. were 0.05-6.25 µg/ml and 6.25-25.0 µg/ml, respectively. And the ranges of minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) of amoxicillin against B. burgdorferi were 0.05-0.39 µg/ml and 0.20-0.78 µg/ml, respectively. The ranges of MIC and MBC of enrofloxacin against Leptospira spp. were 0.05-0.39 µg/ml and 0.05-0.39 µg/ml, respectively. Two strains of B. burgdorferi were resistant to enrofloxacin at the highest concentration tested for MBC (≥100 µg/ml). Therefore, the potential role of tilmicosin in the treatment of leptospirosis and borreliosis should be further evaluated in animal models to understand whether the in vivo studies will confirm in vitro results. All spirochetal isolates were inhibited (MIC) and were killed (MBC) by tilmicosin at concentrations below the limit of testing (≤0.01 µg/ml).Keywords
This publication has 34 references indexed in Scilit:
- Broth Microdilution Susceptibility Testing forLeptospirasppAntimicrobial Agents and Chemotherapy, 2004
- Ceftriaxone Compared with Sodium Penicillin G for Treatment of Severe LeptospirosisClinical Infectious Diseases, 2003
- In Vitro Susceptibility Testing of Four Antibiotics against Borrelia burgdorferi : a Comparison of Results for the Three Genospecies Borrelia afzelii , Borrelia garinii , and Borrelia burgdorferi Sensu StrictoJournal of Clinical Microbiology, 2003
- Lyme DiseasePublished by Elsevier ,2003
- Prevalence of and risk factors for leptospirosis among dogs in the United States and Canada: 677 cases (1970–1998)Journal of the American Veterinary Medical Association, 2002
- Practice Guidelines for the Treatment of Lyme DiseaseClinical Infectious Diseases, 2000
- Cardiovascular effects of the macrolide antibiotic tilmicosin, administered alone and in combination with propranolol or dobutamine, in conscious unrestrained dogsJournal of Veterinary Pharmacology and Therapeutics, 1996
- Tilmicosin antibacterial activity and pharmacokinetics in cowsJournal of Veterinary Pharmacology and Therapeutics, 1995
- Experimental Lyme Disease in Dogs Produces Arthritis and Persistent InfectionThe Journal of Infectious Diseases, 1993
- Long-acting antibiotic formulations in the treatment of calf pneumonia: a comparative study of tilmicosin and oxytetracyclineVeterinary Record, 1991